High prevalence of hypovitaminosis D status in patients with early Parkinson disease

Archives of Neurology

Volumn 68, Issue 3, 2011, Pages 314-319

  Evatt, Marian L ^a,b   DeLong, Mahlon R ^a   Kumari, Meena ^a   Auinger, Peggy ^c   McDermott, Michael P ^c   Tangpricha, Vin ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ATLANTA VA MEDICAL CENTER   (United States)

^c UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ALPHA TOCOPHEROL; SELEGILINE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PREVALENCE; PRIORITY JOURNAL; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

ADULT; AGED; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; HYDROXYCHOLECALCIFEROLS; MALE; MIDDLE AGED; NUTRITIONAL STATUS; PARKINSON DISEASE; SEASONS; SOCIOECONOMIC FACTORS; VITAMIN D; VITAMIN D DEFICIENCY; VITAMINS;

EID: 79952615746     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneurol.2011.30     Document Type: Article

References (33)

1. Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357(3):266-281.
2. Forouhi NG, Luan J, Cooper A, Boucher BJ, Wareham NJ. Baseline serum 25-hydroxy vitamin d is predictive of future glycemic status and insulin resistance: the Medical Research Council Ely Prospective Study 1990-2000. Diabetes. 2008;57(10):2619-2625.
3. Pittas AG, Harris SS, Stark PC, Dawson-Hughes B. The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. Diabetes Care. 2007;30(4):980-986. (Pubitemid 46556596)
4. Jorde R, Waterloo K, Saleh F, Haug E, Svartberg J. Neuropsychological function in relation to serum parathyroid hormone and serum 25-hydroxyvitamin D levels: the Tromsø study. J Neurol. 2006;253(4):464-470. (Pubitemid 43965611)
5. Wilkins CH, Sheline YI, Roe CM, Birge SJ, Morris JC. Vitamin D deficiency is associated with low mood and worse cognitive performance in older adults. Am J Geriatr Psychiatry. 2006;14(12):1032-1040. (Pubitemid 44936995)
6. Kamen DL, Tangpricha V. Vitamin D and molecular actions on the immune system: modulation of innate and autoimmunity. J Mol Med. 2010;88(5):441-450. doi:10.1007/s00109-010-0590-9.
7. Newmark HL, Newmark J. Vitamin D and Parkinson's disease: a hypothesis. Mov Disord. 2007;22(4):461-468.
8. Eyles DW, Smith S, Kinobe R, Hewison M, McGrath JJ. Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. J Chem Neuroanat. 2005;29(1):21-30. (Pubitemid 39602785)
9. Kalueff AV, Tuohimaa P. Neurosteroid hormone vitamin D and its utility in clinical nutrition. Curr Opin Clin Nutr Metab Care. 2007;10(1):12-19. (Pubitemid 44901128)
10. Wang T-T, Tavera-Mendoza LE, Laperriere D, et al. Large-scale in silico and microarray-based identification of direct 1,25-dihydroxyvitamin D3 target genes. Mol Endocrinol. 2005;19(11):2685-2695. (Pubitemid 41577243)
11. Puchacz E, Stumpf WE, Stachowiak EK, Stachowiak MK. Vitamin D increases expression of the tyrosine hydroxylase gene in adrenal medullary cells. Brain Res Mol Brain Res. 1996;36(1):193-196. (Pubitemid 26058893)
12. Lawson DE, Paul AA, Black AE, Cole TJ, Mandal AR, Davie M. Relative contributions of diet and sunlight to vitamin D state in the elderly. Br Med J. 1979;2(6185):303-305. (Pubitemid 9234298)
13. Salamone LM, Dallal GE, Zantos D, Makrauer F, Dawson-Hughes B. Contributions of vitamin D intake and seasonal sunlight exposure to plasma 25-hydroxyvitamin D concentration in elderly women. Am J Clin Nutr. 1994;59(1):80-86. (Pubitemid 24021713)
14. Lips P, van Ginkel FC, Jongen MJ, Rubertus F, van der Vijgh WJ, Netelenbos JC. Determinants of vitamin D status in patients with hip fracture and in elderly control subjects. Am J Clin Nutr. 1987;46(6):1005-1010. (Pubitemid 18032753)
15. Webb AR, Pilbeam C, Hanafin N, Holick MF. An evaluation of the relative contributions of exposure to sunlight and of diet to the circulating concentrations of 25-hydroxyvitamin D in an elderly nursing home population in Boston. Am J Clin Nutr. 1990;51(6):1075-1081.
16. Kim J-S, Ryu S-Y, Yun I, et al. 1α,25-Dihydroxyvitamin D(3) protects dopaminergic neurons in rodent models of Parkinson's disease through inhibition of microglial activation. J Clin Neurol. 2006;2(4):252-257.
17. Shinpo K, Kikuchi S, Sasaki H,MoriwakaF, Tashiro K. Effect of 1,25-dihydroxyvitamin D(3)on cultured mesencephalic dopaminergic neurons to the combined toxicity caused by L-buthionine sulfoximine and 1-methyl-4- phenylpyridine. J Neurosci Res. 2000;62(3):374-382.
18. Smith MP, Fletcher-Turner A, Yurek DM, Cass WA. Calcitriol protection against dopamine loss induced by intracerebroventricular administration of 6-hydroxydopamine. Neurochem Res. 2006;31(4):533-539. (Pubitemid 43873748)
19. Sato Y, Kikuyama M, Oizumi K. High prevalence of vitamin D deficiency and reduced bone mass in Parkinson's disease. Neurology. 1997;49(5):1273-1278. (Pubitemid 27495628)
20. Evatt ML, Delong MR, Khazai N, Rosen A, Triche S, Tangpricha V. Prevalence of vitamin d insufficiency in patients with Parkinson disease and Alzheimer disease. Arch Neurol. 2008;65(10):1348-1352.
21. Parkinson Study Group. DATATOP: a multicenter controlled clinical trial in early Parkinson's disease. Arch Neurol. 1989;46(10):1052-1060.
22. Marras C, McDermott MP, Rochon PA, et al; Parkinson Study Group. Survival in Parkinson disease: thirteen-year follow-up of the DATATOP cohort. Neurology. 2005;64(1):87-93.
23. Sato Y, Kaji M, Tsuru T, Satoh K, Kondo I. Vitamin K deficiency and osteopenia in vitamin D-deficient elderly women with Parkinson's disease. Arch Phys Med Rehabil. 2002;83(1):86-91. (Pubitemid 34052145)
24. Sato Y, Honda Y, Kaji M, et al. Amelioration of osteoporosis by menatetrenone in elderly female Parkinson's disease patients with vitamin D deficiency. Bone. 2002;31(1):114-118. (Pubitemid 34754436)
25. Ginde AA, Liu MC, Camargo CA Jr. Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. Arch Intern Med. 2009;169(6):626-632.
26. Lorefät B, Ganowiak W, Wissing U, Granérus AK, Unosson M. Food habits and intake of nutrients in elderly patients with Parkinson's disease. Gerontology. 2006;52(3):160-168. (Pubitemid 43800678)
27. Lensmeyer GL, Wiebe DA, Binkley N, Drezner MK. HPLC method for 25-hydroxyvitamin D measurement: comparison with contemporary assays. Clin Chem. 2006;52(6):1120-1126. (Pubitemid 43794425)
28. Lissner D, Mason RS, Posen S. Stability of vitamin Dmetabolites in human blood serum and plasma. Clin Chem. 1981;27(5):773-774. (Pubitemid 11073745)
29. Antoniucci DM, Vittinghoff E, Blackwell T, Black DM, Sellmeyer DE. Vitamin D insufficiency does not affect bone mineral density response to raloxifene. J Clin Endocrinol Metab. 2005;90(8):4566-4572. (Pubitemid 41159344)
30. Heaney RP, Davies KM, Chen TC, Holick MF, Barger-Lux MJ. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr. 2003;77(1):204-210. (Pubitemid 36015393)
31. Wolfrath SC, Borenstein AR, Schwartz S, Hauser RA, Sullivan KL, Zesiewicz TA. Use of nutritional supplements in Parkinson's disease patients. Mov Disord. 2006;21(8):1098-1101. (Pubitemid 44336592)
32. Tolosa E, Wenning G, Poewe W. The diagnosis of Parkinson's disease. Lancet Neurol. 2006;5(1):75-86. (Pubitemid 41790698)
33. Jankovic J, Rajput AH, McDermott MP, Perl DP; Parkinson Study Group. The evolution of diagnosis in early Parkinson disease. Arch Neurol. 2000;57(3):369-372. (Pubitemid 30140525)